Davis Polk, HSF act on Chinese biopharma firm’s $335 mln HK IPO

BY Aparna Sai |

Davis Polk & Wardwell and Zhong Lun Law Firm advised Chinese biopharmaceutical company Antengene Corporation on its $335 million IPO in Hong Kong, with Herbert Smith Freehills and Commerce & Finance Law Offices advising the joint sponsors and the underwriters.

S&R, CAM, Khaitan advise on sale of $1.3 bln Bengaluru business park

BY Aparna Sai |

S&R Associates has represented India’s Embassy REIT on its $1.3 billion acquisition of Embassy TechVillage assets from affiliates of sponsors Embassy Group, which were advised by Khaitan & Co.

Asia Deals: Week of November 30

BY Rowena Muñiz |

AZB on NVIDIA's $40 bln deal with Softbank, A&O on PRC’s $4.8 bln sovereign bond, and much more in this week’s Asia Deals roundup.

Asia Deals: Week of November 23

BY Rowena Muñiz |

Linklaters on PRC government’s $4.8 bln bond offering, Khaitan on Embassy’s $1.3 bln deal, and much more in this week’s Asia Deals roundup

Chandler, CC advise on Vietnam’s first certified green loan

BY Aparna Sai |

Thailand’s Chandler MHM has advised Phu Yen TTP Joint Stock Company (Phu Yen JSC) on a $186 million loan to develop and operate a 257MW solar power plant in Hoa Hoi, Phu Yen Province, Vietnam, with Clifford Chance representing the lenders.

Asia Deals: Week of November 16

BY Rowena Muñiz |

O’Melveny on GDS Holdings' $1.67 bln HK secondary listing, Allen & Gledhill on Frasers' $990 mln deal, and much more in this week’s Asia Deals roundup.

Shearman, Davis Polk lead on Chinese cell therapy developer’s $300 mln HK IPO

BY Aparna Sai |

Shearman & Sterling, Fangda Partners and Tian Yuan Law Firm have advised Chinese cancer cell therapy developer JW Therapeutics on its $300 million IPO in Hong Kong, with Davis Polk & Wardwell and Commerce & Finance Law Offices counselling the joint sponsors and underwriters.

Skadden, HSF lead on Chinese education group’s $1.31 bln HK secondary listing

BY Aparna Sai |

Skadden, Arps, Slate, Meagher & Flom, Tian Yuan Law Firm and Conyers have advised China’s New Oriental Education & Technology on its HK$10.13 billion ($1.31 billion) secondary offering on the Hong Kong Stock Exchange, with Herbert Smith Freehills and Jia Yuan Law Offices counselling the joint sponsors and underwriters.

Asia Deals: Week of November 9

BY Rowena Muñiz |

Baker McKenzie on Gaw Capital’s $1.3 bln deal, Conyers, HSF, Jian Yuan, Skadden and Tian Yuan on New Oriental Education’s $1.3 billion listing, and much more in this week’s Asia Deals table.

A&G, A&O lead on nanotech firm’s $384 mln SGX IPO

BY Aparna Sai |

Allen & Gledhill, TMI Associates, Haiwen & Partners and YKVN have advised Nanofilm Technologies International on its S$510.1 million ($383.53 million) initial public offering on the Singapore Exchange Securities Trading (SGX-ST), with Allen & Overy and JunHe counselling the issue managers and bookrunners.

OMM, HSF advise on Chinese pharma firm’s $461 mln HK IPO

BY Aparna Sai |

O'Melveny & Myers, Tian Yuan Law Firm and William Ji & Co. have represented China’s Simcere Pharmaceutical Group on its HK$3.57 billion ($460.6 million) Hong Kong IPO, with Herbert Smith Freehills and Jingtian & Gongcheng advising the joint sponsors.

Asia Deals: Week of October 26

BY Rowena Muñiz |

A&O and Linklaters on PRC’s $6 bln bonds offering, CAM and Khaitan on Brookfield’s $2 bln acquisition of RMZ Corp portfolio, and much more in this week’s Asia Deals roundup.